Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer

ISSN： 0378-7966

Source： European Journal of Drug Metabolism and Pharmacokinetics, Vol.36, Iss.3, 2011-09, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport

By Senarathna S. M. D. K. Ganga Crowe A.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 798-803

Govi-Verlag

Access to resources Recommend Favorite

A Transcellular Assay to Assess the P-gp Inhibition in Early Stage of Drug Development

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 285-291

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products

By Trudeau Vance L. Drouin Cathy E. Panahi Mitra Arnason J. T. Foster Brian C. Budzinski Jason W.

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 9, 2007-09 ,pp. : 966-978

NRC Research Press

Access to resources Recommend Favorite

The Caco-2 cell monolayer: usefulness and limitations

By Sun Huadong Chow Edwin CY Liu Shanjun Du Yimin Pang K Sandy

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 395-411

Informa Healthcare

Access to resources Recommend Favorite

Mipafox Differential Inhibition Assay for Heart Muscle Cholinesterases: Substrate Specificity and Inhibition of Three Isoenzymes by Physostigmine and Quinidine

By Chemnitius J.-M. Haselmeyer K.-H. Gonska B.D. Kreuzer H. Zech R.

General Pharmacology, Vol. 28, Iss. 4, 1997-04 ,pp. : 567-575

Elsevier

Access to resources Recommend Favorite